JP Morgan Chase
MDCO

JP Morgan Chase’s Medicines Co MDCO Stock Holding History

JP Morgan Chase’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-592,700
Closed -$50.3M – 5979
2019
Q4 		$50.3M Buy
592,700
+542,700
+1,085% +$36.2M 0.01% 961
2019
Q3 		$2.5M Sell
50,000
-65,000
-57% -$2.59M ﹤0.01% 3259
2019
Q2 		$4.09M Buy
115,000
+90,000
+360% +$2.94M ﹤0.01% 2784
2019
Q1 		$699K Sell
25,000
-59,500
-70% -$1.4M ﹤0.01% 4010
2018
Q4 		$1.62M Buy
84,500
+25,000
+42% +$582K ﹤0.01% 3427
2018
Q3 		$1.78M Buy
59,500
+21,500
+57% +$810K ﹤0.01% 3540
2018
Q2 		$1.4M Hold
38,000
– – ﹤0.01% 3646
2018
Q1 		$1.25M Buy
38,000
+26,200
+222% +$819K ﹤0.01% 3550
2017
Q4 		$323K Buy
11,800
+2,000
+20% +$61.6K ﹤0.01% 4259
2017
Q3 		$359K Hold
9,800
– – ﹤0.01% 3933
2017
Q2 		$372K Hold
9,800
– – ﹤0.01% 3828
2017
Q1 		$479K Sell
9,800
-18,200
-65% -$830K ﹤0.01% 3728
2016
Q4 		$950K Hold
28,000
– – ﹤0.01% 3472
2016
Q3 		$1.06M Sell
28,000
-105,000
-79% -$3.96M ﹤0.01% 3108
2016
Q2 		$4.47M Buy
133,000
+107,700
+426% +$3.8M ﹤0.01% 2370
2016
Q1 		$804K Buy
+25,300
New +$826K ﹤0.01% 3156

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

JP Morgan Chase's MDCO Position: Q1 2020 in Review

JP Morgan Chase sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 547,883 shares — an estimated $46.5M sold.

JP Morgan Chase first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $46.5M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • JP Morgan Chase reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • JP Morgan Chase sold 547,883 Medicines Co shares in Q1 2020, an estimated $46.5M.
  • JP Morgan Chase first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
  • JP Morgan Chase's Medicines Co position peaked at $46.5M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.